Schedule 13G ownership disclosure

INOVIO PHARMACEUTICALS INC

Common Stock · CUSIP: 45773H409

Event date: 2024-12-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Stonepine Capital Management, LLC

    Shares: 1,916,666.00 · Class: 5.2%

  • Stonepine Capital, L.P.

    Shares: 1,916,666.00 · Class: 5.2%

  • Stonepine GP, LLC

    Shares: 1,916,666.00 · Class: 5.2%

  • Jon M. Plexico

    Shares: 1,916,666.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000779
Form type
SCHEDULE 13G
Filer
INOVIO PHARMACEUTICALS, INC.
CIK
CIK 1055726
Filed
Dec 23, 2024
Reporting period
Dec 17, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub